AI总结:
Scan me!
共19篇 平均IF=4.95 (1.1-18.7)更多分析
  • 打开PDF
    1. 2004 J Cardiovasc Pharmacol 搭桥(不停跳)_transCN.pdf
  • 1区Q1影响因子: 18.7
    打开PDF
    2. 10 for 10!
    作者:Cosma Christine , Hinson Ella , Goyal Lakshmi
    期刊:Cell host & microbe
    日期:2017-08-09
    DOI :10.1016/j.chom.2017.07.015
  • 打开PDF
    3. 2007--中华临床医师杂志-- 尼可地尔后处理联合预处理对离体心肌缺血/再灌注的作用研究(心外).pdf
  • 打开PDF
    4. 2001--江苏医药杂志--尼可地尔超极化心脏停搏心肌保护的实验研究(讨论部分,心外).pdf
  • 打开PDF
    5. 2004--中国CPB杂志--尼可地尔改善心脏停搏液对心脏的保护作用.pdf
  • 打开PDF
    6. 1999--广东医学--尼可地尔停跳心脏效果的初步研究(心外、麻醉).pdf
  • 打开PDF
    7. 2004--中国体外循环杂志--尼可地尔改善心脏停搏液对心脏的保护作用.pdf
  • 打开PDF
    8. 2007--中国血液流变学杂志--尼可地尔+阜外改良器官保护液对冠状动脉旁路移植术大隐静脉血管桥舒张功能的影响.pdf
  • 打开PDF
    9. 2005--中国体外循环杂志-- 尼可地尔及罂粟碱对冠状动脉旁路移植术大隐静脉血管桥血管舒张功能的影响.pdf
  • 打开PDF
    10. 2003--中国体外循环杂志--尼可地尔对大隐静脉舒张功能的保护作用.pdf
  • 打开PDF
    11. 2001--医学研究生学报--尼可地尔超极化心脏停搏心肌保护剂量-效应关系的实验研究(参考文献,心外).pdf
  • 打开PDF
    12. 2012--中华胸心外科血管杂志-- 尼可地尔对冠状动脉内皮细胞功能的影响.pdf
  • 2区Q1影响因子: 6.8
    打开PDF
    13. Myocardial protection by nicorandil during open-heart surgery under cardiopulmonary bypass.
    作者:Chinnan N K , Puri G D , Thingnam S K S
    期刊:European journal of anaesthesiology
    日期:2006-05-24
    DOI :10.1017/S0265021506000676
    BACKGROUND:To evaluate the myocardial protective effect of nicorandil when used as an adjuvant to cold hyperkalaemic cardioplegia in open-heart surgery. METHODS:Patients who underwent surgery under cardiopulmonary bypass (CPB) for mitral valve replacement (MVR, 23 patients) or coronary artery bypass grafting (CABG, 24 patients) were entered in a double-blind study. The patients were randomized to a nicorandil Group (N) or placebo Group (P). Nicorandil 0.1 mg kg-1 (Group N), or normal saline (Group P), were administered at three time points: (1) after aortic cannulation, but prior to going on CPB, (2) 5 min before aortic cross-clamping and (3) 5 min before reperfusion. The following variables were studied: (a) time until electromechanical arrest after cardioplegia administration (Tarrest), (b) time until return of electromechanical activity after aortic cross-clamp removal (Trecovery), (c) incidence of postoperative myocardial infarction or low output syndromes (d) dysrhythmias requiring intervention after aortic cross-clamp removal and (e) haemodynamic changes after nicorandil administration. RESULTS:The Tarrest after cardioplegia administration was significantly faster in nicorandil group in both MVR and CABG patients (P 75 IU L-1 in MVR patients was significantly lower in the Group N than in placebo patients (P < 0.05). However, in CABG patients there was no such significant difference. The incidence of dysrhythmias requiring intervention after aortic cross-clamp removal was also less in Group N. Administration of 0.1 mg kg-1 boluses of nicorandil did not cause significant haemodynamic changes or precipitate dysrhythmias in any patient. CONCLUSION:Nicorandil enhances the myocardial protective effect of cold hyperkalaemic cardioplegia in cardiac surgery patients.
  • 4区Q2影响因子: 2.1
    打开PDF
    14. Cardioprotective effects of nicorandil in patients undergoing on-pump coronary artery bypass surgery.
    作者:Yamamoto Shinichi , Yamada Tatsuya , Kotake Yoshifumi , Takeda Junzo
    期刊:Journal of cardiothoracic and vascular anesthesia
    日期:2008-05-22
    DOI :10.1053/j.jvca.2008.02.011
    OBJECTIVE:The purpose of this study was to assess the cardioprotective effects of nicorandil in patients undergoing coronary artery bypass graft (CABG) surgery with cardiopulmonary bypass (CPB). DESIGN:A prospective, double-blind, randomized clinical study. SETTING:A university hospital. PARTICIPANTS:Thirty-two patients undergoing elective CABG surgery. INTERVENTIONS:Patients were randomized into 2 groups: the nicorandil and placebo groups. In the nicorandil group, intravenous nicorandil infusion was started after the induction of anesthesia by a loading dose of 0.1 mg/kg, followed by a continuous infusion of 0.1 mg/kg/h until 2 hours after CPB, then decreased to 0.05 mg/kg/h, and discontinued at the end of surgery. The placebo group received the same volume of saline. Arterial blood was sampled, and serum troponin T (TnT) and CK-MB were measured at the following 4 stages: after the induction of anesthesia (baseline), 2 hours after CPB, the first postoperative day (POD), and the third POD. MEASUREMENTS AND MAIN RESULTS:TnT concentrations were similar at baseline and increased with a peak on the first POD in both groups. In the nicorandil group, TnT concentration returned to the baseline value at the third POD, and the time course of TnT showed significantly lower levels (p = 0.012). CK-MB concentrations were similar at baseline, increased and peaked at 2 hours after CPB, and returned to the baseline on the third POD in both groups. There were no significant differences between the groups with respect to the changes in CK-MB concentrations. CONCLUSIONS:The nicorandil group showed lower concentrations of TnT, suggesting that intraoperative administration of nicorandil may provide a degree of myocardial protection in CABG surgery.
  • 1区Q1影响因子: 8.8
    打开PDF
    15. Randomized clinical trial of the effect of pneumoperitoneum on cardiac function and haemodynamics during laparoscopic cholecystectomy (Br J Surg 2004; 91: 848-854).
    作者:Alishahi S
    期刊:The British journal of surgery
    日期:2005-03-01
    DOI :10.1002/bjs.4970
  • 3区Q1影响因子: 3.1
    打开PDF
    16. Reply to: Kampf G, Ostermeyer C. World Health Organization-recommended hand-rub formulations do not meet European efficacy requirements for surgical hand disinfection in five minutes (J Hosp Infect 2011;78:123-127).
    作者:Allegranzi B , Boyce J M , Dharan S , Kim E M , Rotter M , Suchomel M , Voss A , Widmer A , Pittet D
    期刊:The Journal of hospital infection
    日期:2012-03-24
    DOI :10.1016/j.jhin.2011.08.027
  • 4区Q3影响因子: 1.1
    打开PDF
    17. Cutaneous inflammatory myofibroblastic tumor with CARS-ALK fusion: Case report and literature review.
    期刊:Journal of cutaneous pathology
    日期:2022-06-06
    DOI :10.1111/cup.14261
    Cutaneous inflammatory myofibroblastic tumors (IMT) constitute a rare entity, generating a diagnostic pitfall when diagnosing spindle cell proliferation within the dermis. Raising awareness of this tumor among dermatopathologists remains vital in differentiating it from common cutaneous tumors such as fibrous histiocytoma, atypical fibroxanthoma, melanoma, poorly differentiated carcinoma, and other more aggressive tumors. Accurate diagnosis of IMT aids in ensuring appropriate management and follow-up for patients while preventing unnecessary harm and overtreatment. Here we report a case of a 38-year-old female with a painless, slow-growing nodule of the left posterior scalp initially diagnosed as a dermatofibroma. The histopathological examination revealed an ill-defined dermal nodule of spindled cells without connection or infiltration of the epidermis. At high power, the cells were arranged in fascicles with a prominent background of lymphocytic infiltrate. Immunohistochemical analysis showed strong diffuse immunoreactivity for anaplastic lymphoma kinase (ALK), and targeted RNA sequencing identified a CARS-ALK fusion ultimately confirming the accurate diagnosis of a cutaneous IMT.
  • 打开PDF
    18. 2004 J Cardiovasc Pharmacol 搭桥(不停跳).pdf
  • 打开PDF
    19. 2015 术前双联抗血小板药物治疗对非体外循环冠状动脉旁路移植术围手术期出血的影响.pdf

加载中

logo logo
$!{favoriteKeywords}